Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Unique biological properties and molecular mechanism of 5,6-bridged quinolones.

Macinga DR, Renick PJ, Makin KM, Ellis DH, Kreiner AA, Li M, Rupnik KJ, Kincaid EM, Wallace CD, Ledoussal B, Morris TW.

Antimicrob Agents Chemother. 2003 Aug;47(8):2526-37.

2.

Development and use of a high-throughput bacterial DNA gyrase assay to identify mammalian topoisomerase II inhibitors with whole-cell anticancer activity.

Roychoudhury S, Makin KM, Twinem TL, Stanton DT, Nelson SL, Catrenich CE.

J Biomol Screen. 2003 Apr;8(2):157-63.

PMID:
12844436
3.

Staphylococcus aureus mutants isolated via exposure to nonfluorinated quinolones: detection of known and unique mutations.

Roychoudhury S, Twinem TL, Makin KM, Nienaber MA, Li C, Morris TW, Ledoussal B, Catrenich CE.

Antimicrob Agents Chemother. 2001 Dec;45(12):3422-6.

4.

Activity of non-fluorinated quinolones (NFQs) against quinolone-resistant Escherichia coli and Streptococcus pneumoniae.

Roychoudhury S, Twinem TL, Makin KM, McIntosh EJ, Ledoussal B, Catrenich CE.

J Antimicrob Chemother. 2001 Jul;48(1):29-36.

PMID:
11418510
5.

Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.

Roychoudhury S, Catrenich CE, McIntosh EJ, McKeever HD, Makin KM, Koenigs PM, Ledoussal B.

Antimicrob Agents Chemother. 2001 Apr;45(4):1115-20.

6.

Virulence of coccoid and bacillary forms of Helicobacter pylori in gnotobiotic piglets.

Eaton KA, Catrenich CE, Makin KM, Krakowka S.

J Infect Dis. 1995 Feb;171(2):459-62.

PMID:
7844390
7.

Characterization of the morphologic conversion of Helicobacter pylori from bacillary to coccoid forms.

Catrenich CE, Makin KM.

Scand J Gastroenterol Suppl. 1991;181:58-64.

PMID:
1866596

Supplemental Content

Loading ...
Support Center